Barbara Valkova Khan
About Barbara Valkova Khan
Barbara Valkova Khan is an Executive Business Manager at Alkermes in Bakersfield, California, with extensive experience in pharmaceutical sales and marketing.
Title
Barbara Valkova Khan holds the position of Executive Business Manager at Alkermes in the Bakersfield, California area.
Current Role at Alkermes
As an Executive Business Manager at Alkermes, Barbara Valkova Khan oversees various business operations and strategic initiatives within the Bakersfield, California area. Her role involves managing key business functions and driving strategic projects that align with the company's objectives.
Previous Experience
Barbara Valkova Khan has an extensive background in the pharmaceutical industry. She served as a Neuroscience Therapeutic Specialist at Sunovion Pharmaceuticals Inc. from 2010 to 2015 in the Bakersfield, California area. Prior to that, she worked as a Sales Representative for CNS at Johnson & Johnson's Ortho-McNeil-Janssen from 2006 to 2010. She also spent three years as a Sales Representative at GSK from 2003 to 2006.
Education and Marketing Expertise
Barbara Valkova Khan earned both her Bachelor of Arts (B.A.) and Master of Business Administration (MBA) in Marketing from California State University-Bakersfield. She completed her B.A. from 1996 to 2000 and her MBA from 2000 to 2002, gaining a strong foundation in marketing principles and business strategies.
Achievements and Recognition
Barbara Valkova Khan has a history of professional achievements. She played a pivotal role in the successful launch of the injectable medication Aristada for schizophrenia treatment in outpatient and hospital markets. She won the President Circle of Excellence in 2017 and is in contention for the same award in 2018. Consistently ranked among the top 2 representatives for volume and market share since the launch of Aristada, Barbara also achieved 'formulary status' for three out of five local hospitals.
Industry Contributions
Barbara Valkova Khan has contributed significantly to the pharmaceutical industry. She was a member of the National Insight Counsel, participating in various divisions including marketing project management and Aristada Care Support (ACS) from 2016 to 2018. Her performance has been consistently rated as 'outstanding' and 'exceeding expectations' in all categories of performance metrics for the years 2015 through 2017.